We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Researchers Stress Cancer Cells for Better Treatment Options

By LabMedica International staff writers
Posted on 10 Dec 2014
Print article
Employing metabolic stress to destroy cancer cells could create new approaches for better targeted therapies that will not hurt normal cells and have no unpleasant side effects.

Researchers from the University of Adelaide in South Australia (Adelaide) revealed that chromosomal instability, which is a major characteristic of quickly dividing cancer cells, makes them stressed and susceptible to mild metabolic disruption.

Metabolism is the normal process by which the body converts food into energy. “A common problem in treating cancers is that they don’t respond to chemotherapy, or they respond for a while, but then come back,” stated lead author Dr. Stephen Gregory, senior postdoctoral fellow with the University’s School of Molecular and Biomedical Sciences.

“One reason this happens is because a tumor is usually not made up of identical cells but rather a diverse population of cells that changes all the time, losing, and gaining chromosomes as they divide—so-called chromosomal instability. Sooner or later they change enough to be able to resist chemotherapy drugs. Our research has shown that chromosomal instability has some consequences for cells—they get stressed, and it only takes a small metabolic push to kill them.”

Traditional chemotherapy is also very toxic to all dividing cells, especially affecting cells in hair follicles, blood, and the gut lining, frequently causing hair loss, pain, and making patients unwell. “We need to find ways to target cancer cells without affecting other normal dividing cells,” said Dr. Gregory.

The researchers stimulated chromosomal instability in the fly Drosophila and discovered that the unstable cells were “on the edge” of how much stress they could endure. “This is significant because a change in metabolism is something people cope with very well normally,” said Dr. Gregory. “That means that we hope to be able to develop treatments that have no side effects on patients, but are able to kill off the unstable tumor cells that cause relapses.”

Dr. Gregory noted that this may give some support to hypotheses of alternative treatments such as going on a drastic diet. “People who have advanced cancer which isn’t responding to chemotherapy often try a range of different treatments such as a radical diet in the hope it may help,” he said. “In some situations, it may in fact work; but we hope to be able to point the way to a more targeted approach—finding the most appropriate steps for intervention in the metabolic process that will give the best results.”

The research was published October 27, 2014, in the journal Oncogene.

Related Links:

University of Adelaide in South Australia


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.